<DOC>
	<DOCNO>NCT02303873</DOCNO>
	<brief_summary>Alendronate consider alternative therapy osteogenesis imperfecta ( OI ) significantly increase areal bone mineral density ( BMD ) Z score , decreased fracture incidence , inhibit bone resorption biomarkers . Alendronate exert beneficial role different age bracket , especially young patient OI .</brief_summary>
	<brief_title>Efficacy Safety Alendronate Chinese Children Adolescents With Osteogenesis Imperfecta</brief_title>
	<detailed_description />
	<mesh_term>Osteogenesis Imperfecta</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>1. child adolescent age 018 year , 2. either history least minorimpact fracture age sex adjust areal BMD Z score 1.0 less lumbar spine total hip ; 3. without blue sclera , impaired hearing , joint hypermobility dentinogenesis imperfecta ; 4. without slim long bone ; without cranial epactal bone , sign multiple fracture , bony deformity skeletal Xray film . 1. previous history rickets , hyperparathyroidism , metabolic inherit bone disease ; malignant disease ; coeliac disease ; hyperthyroidism ; 2. therapy history BPs within recent two year ; severe renal failure ( creatinine clearance &lt; 40 ml/min ) , chronic liver disease ; severe diseases gastrointestinal tract ; 3. unable keep upright least 30 minute daily .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>